Home health nursing is a noble profession, writes columnist Ari Anderson, who shares what the experience is like in his own ...

ARD-1676 showed promise for SBMA in a study, which found it can break down the AR protein that's faulty in the disorder.

Columnist Kevin Schaefer may talk openly about his life with a disability, but he has many other passions that contribute to ...

A technique to estimate the health of specialized nerve cells may help predict patient response to Zolgensma gene therapy, a ...

Spinraza stabilizes lung function over several years in SMA adults, with initial breathing capacity predicting long-term ...

The FDA has rejected apitegromab as a treatment for spinal muscular atrophy due to issues at a manufacturing facility.

Columnist Connie Chandler has an elite team of supermoms who leap into action with love and compassion in her ongoing battle with SMA.

The FDA declined to approve a higher dose of nusinersen – the medication in Biogen’s spinal muscular atrophy treatment ...

For columnist Jasmine Ramos, who's living with SMA, turning 30 prompted both excitement and uncertainty about the years ahead ...

A spinal muscular atrophy expert at the Muscular Dystrophy Association discusses research breakthroughs and future treatment ...

For columnist Helen Baldwin, being able to care for others — including her late son, Jeffrey — in times of need has been a ...

Columnist Connie Chandler may use a wheelchair, but that doesn't mean she can't enjoy fun activities — a fact that often ...